Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
COMy 2022: Multiple myeloma roundup
Prof Philippe Moreau - University Hospital of Nantes, Nantes, France
COMy 2022: Multiple myeloma roundup ( Prof Philippe Moreau - University Hospital of Nantes, Nantes, France )
24 May 2022
Lymphoma Coalition: Challenges for Ukrainian haematological cancer patients
Prof Natacha Bolaños
Lymphoma Coalition: Challenges for Ukrainian haematological cancer patients ( Prof Natacha Bolaños )
28 Apr 2022
Natural killer cells complexed with a bispecific antibody may provide new treatm...
Prof Yago Nieto - The University of Texas MD Anderson Cancer Center, Houston, US...
Natural killer cells complexed with a bispecific antibody may provide new treatment option for patients with advanced lymphoma ( Prof Yago Nieto - The University of Texas MD Anderson Cancer Center, Houston, USA )
26 Apr 2022
Minimal residual disease in multiple myeloma
Prof Ola Landgren - University of Miami, Miami, USA
Minimal residual disease in multiple myeloma ( Prof Ola Landgren - University of Miami, Miami, USA )
8 Mar 2022
Real-world evidence on PET use in Hodgkin lymphoma: An Argentinian perspective
Dr Marta Zerga - Hospital Alemán , Buenos Aires, Argentina
Real-world evidence on PET use in Hodgkin lymphoma: An Argentinian perspective ( Dr Marta Zerga - Hospital Alemán , Buenos Aires, Argentina )
3 Mar 2022
Cancer nursing in India: Tumour lysis syndrome
Dr Krishnamani Kalpathi - American Oncology Institute, Hyderabad, India
Cancer nursing in India: Tumour lysis syndrome ( Dr Krishnamani Kalpathi - American Oncology Institute, Hyderabad, India )
28 Feb 2022
Cancer nursing in India: Febrile neutropenia
Dr Krishnamani Kalpathi - American Oncology Institute, Hyderabad, India
Cancer nursing in India: Febrile neutropenia ( Dr Krishnamani Kalpathi - American Oncology Institute, Hyderabad, India )
28 Feb 2022
Brentuximab vedotin and CHP benefit over CHOP for CD30-positive PTCL
Dr Juliana Pereira & Dr Steven Horwitz
Brentuximab vedotin and CHP benefit over CHOP for CD30-positive PTCL ( Dr Juliana Pereira & Dr Steven Horwitz )
22 Feb 2022
PET scanning in patients with classical Hodgkin lymphoma outside of Europe and N...
Prof Mark Hertzberg - University of New South Wales, Sydney, Australia
PET scanning in patients with classical Hodgkin lymphoma outside of Europe and North America ( Prof Mark Hertzberg - University of New South Wales, Sydney, Australia )
22 Feb 2022
Frontline treatment with single agent pembrolizumab followed by AVD chemotherapy...
Prof Pamela Allen - Emory University School of Medicine, Georgia, USA
Frontline treatment with single agent pembrolizumab followed by AVD chemotherapy for classic Hodgkin lymphoma ( Prof Pamela Allen - Emory University School of Medicine, Georgia, USA )
22 Dec 2021
Efficacy and safety of selinexor in patients with myelofibrosis refractory or in...
Prof Srinivas Tantravahi - University of Utah, Salt Lake City, USA
Efficacy and safety of selinexor in patients with myelofibrosis refractory or intolerant to JAK inhibitors ( Prof Srinivas Tantravahi - University of Utah, Salt Lake City, USA )
20 Dec 2021
Significance of gut microbiota in patients receiving CAR T cell immunotherapy
Prof Marco Ruella - University of Pennsylvania, Philadelphia, USA
Significance of gut microbiota in patients receiving CAR T cell immunotherapy ( Prof Marco Ruella - University of Pennsylvania, Philadelphia, USA )
17 Dec 2021